Growth led by new ventures; profitability still deferred

Delivered result confirms ₹48,716.2 Cr (₹48.7K Cr)

Delivered result shows +21.4% YoY

Segment data not independently verified but management disclosed in call

Calculation from segment disclosures; implies core standalone scale

Magnitude not disclosed; unit still pre-profitable at ₹1.6K Cr revenue

Segment data not independently verified

Historical claim; not verifiable from this quarter alone

FY27 Q1 64% YoY, explicit >50% YoY FY27 guidance, ₹10K Cr FY28 target reaffirmed. Prior guidance was high double-digit; delivery is exceeding.

Breakeven deferred from $1B (₹8.5K Cr) to exit FY27 at higher run rate (₹10K+ Cr). Timeline front-loaded via investment acceleration.

12% YoY consolidat volume growth at 41.31 MT scale; EBITDA also +12%. Prior guidance was steady state; delivery shows acceleration.

Specialty fiber 27% of mix (was 21% prior). Revenue +12% despite volume -4%, driven by export pricing and product mix.

EBITDA +16% while revenue +10%; specialty chemical margin expansion and higher realization drive outperformance.

Q1 abnormal due to industry price increases causing channel stocking. Revenues have stocking component that will normalize. Better to assess on longer-term basis. FY27 guidance over 50% YoY maintained.

Consistent stand: once reach ₹10,000 Cr revenue, will become profitable. Not changing that stand.

Old inventory provided cushion; price increases phased across quarter. Volume was mix of consumer demand + dealer stocking (will unwind Q2). Q2 likely weaker due to monsoons + inventory normalization. By Q3 should stabilize.

Difficult to predict. Daily pricing mechanism used; no large inventory positions. Will sell Q1 higher-cost inventory in Q2, creating margin pressure. Market volatile but pricing discipline maintained.

Earlier $1B guidance, but front-loaded investment in people/tech accelerated trajectory. Current estimate exit FY27 at EBITDA breakeven. Revenue run rate also fast-tracked.

Will organize separate session. Grasim major investor but best answered by Renewables management team.

Aditya Birla brand most valuable asset; transitioning to structured governance model consistent with global best practices. Royalty reasonable at 0.25% with upper cap.

Surge in sulfur, caustic input costs passed through. Exports strong due to geopolitical factors (China demand, dollar strengthening). Domestic realization increase similar to international.

Industry cyclical but Grasim has very strong India position. Operating rates near 100%. Depends on input prices and demand. Cotton constraints will support fiber demand. Lyocell expansion adds structural support.

Explicit target reiterated; FY27 >50% YoY growth reconfirmed. Based on distribution scale, brand momentum, and premium mix expansion. Raw material headwinds acknowledged but managed via pricing.

Q1 annualized ~₹10K already achieved; breakeven timing front-loaded via acceleration. Private label scaling as margin lever.

24 consecutive quarters of YoY growth; core cement, chemicals, fibers showing steady 10–12% growth; new ventures accelerating.

Currently loss-making; profitability deferred to FY28. Requires margin expansion at scale. Premium mix (65% of value) and cost absorption via pricing critical.

Earlier $1B guidance shifted to higher run rate (₹10K+ Cr). Timing front-loaded. Working capital financing and private label as levers.

12% volume growth flowing to 12% EBITDA growth. Green energy (45.6% mix) and lower logistics/power costs supporting.

Specialty fiber 27% of mix (from 21%); export pricing strong due to geopolitical factors. Sustainability depends on global demand.

Q1 spent ₹375 Cr (~12% of annual budget). Growth capex focused on Lyocell (Phase 1 detailed engineering underway; Phase 2 in environmental clearance) and new ventures.

Birla Opus (₹1.6K Cr revenue) loss-making; profitability promised only at ₹10K Cr by FY28. Birla Pivot at EBITDA breakeven exit FY27. Both depend on continued scale + margin expansion; no current margin cushion to absorb cost shocks.

Paints absorbed 8.8% cumulative price increase in Q1; COGS inflation 20–25%. More pricing expected in Q2. If cost inflation accelerates or demand weakens, margin pressure persists. Q2 monsoons + inventory normalization will limit volume growth.

Middle East crisis injected volatility into B2B procurement (Pivot saw demand timing effects, not demand loss). China property weakness affecting fiber demand. Shipping/logistics disruptions. Tariff uncertainty on epoxy exports. Daily pricing mechanisms in chemicals reflect inability to take large positions.

Grasim committing <₹1,000 Cr FY27 to Renewables transaction (close December 2026). Stake/structure TBD. AB Renewables management team leading but Grasim major investor. Capital locked in long-duration infrastructure; leverage could exceed 2x EBITDA if other investments accelerate.

Management explicitly noted Q1 had abnormal channel stocking due to industry price increases. Dealers loaded up before pricing; this will reverse in Q2. Monsoons seasonally weaker. Management expects normalization by Q3. Risk: if consumer demand slower than expected, absolute revenue may disappoint.